A new bill introduced by US Congressman Edward Markey (D-Mass.) to the House of Representatives calls for tougher reporting requirements to ClinicalTrials.gov, says Peter Mansell at PharmaTimes. The proposed legislation, called the Trial and Experimental Studies Transparency, or TEST, Act of 2012, would require that results from all clinical trials be posted to the database within a year of the trial's end. Additionally, it says that trials would need to be registered prior to enrolling any participants and that the National Institutes of Health and the Food and Drug Administration have to report to Congress on new database standards. Mansell adds that the bill also calls for sponsors of trials conducted outside the US, but that plan to market in the US, to also have to register with and report to the database.
Aug 08, 2012